Delta Lloyd’s NxStage Medical Inc. NXTM Stock Holding History

Delta Lloyd’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$4.64M	Buy	185,000 +10,000	+6%	+$248K	0.13%	165
2017 Q1	$4.7M	Hold	175,000	–	–	0.14%	148
2016 Q4	$4.59M	Hold	175,000	–	–	0.14%	150
2016 Q3	$4.37M	Hold	175,000	–	–	0.14%	132
2016 Q2	$3.79M	Hold	175,000	–	–	0.13%	132
2016 Q1	$2.62M	Buy	+175,000	New	+$2.93M	0.09%	183
2013 Q4	–	Sell	-86,500	Closed	-$1.14M	–	625
2013 Q3	$1.14M	Hold	86,500	–	–	0.04%	224
2013 Q2	$1.24M	Buy	+86,500	New	+$1.09M	0.05%	203

Other funds holding NXTM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

PCM

Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return

Delta Lloyd's NXTM Position: Q2 2017 in Review

Delta Lloyd increased its NxStage Medical Inc. (NXTM) stake by 5.7% in Q2 2017, buying an estimated $248K and bringing the position to 185,000 shares worth $4.64M. The position accounts for 0.13% of the portfolio, ranked #165.

Delta Lloyd first reported a position in NXTM in Q2 2013 and has held it in 8 quarters since. The position peaked at $4.7M in Q1 2017. 163 funds tracked by Wall St. Rank hold NXTM as of Q2 2017.

Delta Lloyd held 185,000 shares of NxStage Medical Inc. worth $4.64M as of Q2 2017.
Delta Lloyd bought 10,000 NxStage Medical Inc. shares in Q2 2017, an estimated $248K.
NxStage Medical Inc. made up 0.13% of Delta Lloyd's portfolio in Q2 2017, its #165 holding.
Delta Lloyd first reported a position in NxStage Medical Inc. in Q2 2013 and has held it in 8 quarters since.
Delta Lloyd's NxStage Medical Inc. position peaked at $4.7M in Q1 2017.
163 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q2 2017.

Based on Delta Lloyd's 13F filing for Q2 2017, filed 9 Aug 2017.